XORTX Therapeutics XRTX
NASDAQ XRTX
$1.73 +0.04 (+2.37%)
At close: Oct 1, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) Amortization - Intangibles (2020 - 2026)

Updated

XORTX Therapeutics' Amortization - Intangibles came in at $3,638 for the quarter ended Jun 30, 2026, down 46.4% from $6,789 a year earlier but up 5.1% from the prior quarter.

Analysis

XORTX Therapeutics (XRTX) Amortization - Intangibles (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, XORTX Therapeutics reported Amortization - Intangibles of $20,173, down 23.4% year-over-year; for the year ended Dec 31, 2025, it came in at $26,385, down 15.1% from the prior year.

  • Amortization - Intangibles carries a five-year compound annual growth rate of 11.6% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Amortization - Intangibles was $31,070 in the year ended Dec 31, 2024 (-53.4%), $66,632 in the year ended Dec 31, 2023 (+290.2%), $17,077 in the year ended Dec 31, 2022 (+19.7%) and $14,266 in the year ended Dec 31, 2021 (-6.5%).
  • The five-year range for quarterly Amortization - Intangibles is -$1,862 (the quarter ended Sep 30, 2023) to $48,742 (the quarter ended Mar 31, 2023).
  • Year-over-year, Amortization - Intangibles has declined for three consecutive quarters, with an average decline of 16.9% over the last seven quarters.
  • The fastest year-over-year change in Amortization - Intangibles over five years came in the quarter ended Mar 31, 2023 (growth of 919.5%), and the weakest in the quarter ended Mar 31, 2024 (a decline of 75.6%).
  • Business Quant data shows XRTX's Amortization - Intangibles at $3,460 (quarter ended Mar 31, 2026), $6,578 (quarter ended Dec 31, 2025) and $6,497 (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 XORTX Therapeutics 1.60 Mn -1.70 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3,638.00
Mar 31, 2026 3,460.00
Dec 31, 2025 6,578.00
Sep 30, 2025 6,497.00
Jun 30, 2025 6,789.00
Mar 31, 2025 6,521.00
Dec 31, 2024 6,631.00
Sep 30, 2024 6,389.00
Jun 30, 2024 6,164.00
Mar 31, 2024 11,886.00
Dec 31, 2023 6,060.00
Sep 30, 2023 -1,862.00
Jun 30, 2023 13,692.00
Mar 31, 2023 48,742.00
Dec 31, 2022 5,721.00
Sep 30, 2022 3,749.00
Jun 30, 2022 7,652.03
Mar 31, 2022 4,781.00
Dec 31, 2021 4,739.00
Sep 30, 2021 2,853.52
API Access

XORTX Therapeutics Amortization - Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-intangibles&ticker=XRTX&period=max&api_key=YOUR_API_KEY